The federal Government will invest $25 million in research to improve the safe use of medicines and medicines intervention by pharmacists.

Venous thromboembolism (VTE) is the third most common cardiovascular disease in the world. Every year, 30,000 people in Australia develop VTE, at a cost of $1.72 billion to the Australian health system.

Air pollution is making us sick according to local and global research, including a study linking exposure to air pollution with subsequent acute cardiac...

Two pharmacists were honoured at PSA’s Consultant Pharmacist Conference (CPC26), held from 29–31 May 2026 on the Gold Coast.

With vaping rates rising and regulatory changes reshaping access, pharmacists play an increasingly important role.

PSA pharmacists share their clinical skills on diabetes, dengue fever and malaria. In an innovative initiative that bodes well for future collaboration between pharmacists in...